Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0013421 (
dystonia
)
8,418
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The aetiology of
dystonia
in complex regional pain syndrome (CRPS-I) is incompletely understood. In primary
dystonia
, somatosensory-evoked potentials (SSEP) after spatially or temporally separated stimulation revealed impaired central sensory integration. Information on somatosensory processing in
dystonia
in CRPS-I patients may provide better insight into the underlying pathophysiological mechanism. We studied SSEPs in 33 patients with CRPS-I and
dystonia
and 19 healthy controls. N9,
N14
, N20 and N35 amplitudes were recorded after paired stimulation of median and ulnar nerves ("spatial") and after stimulation of both nerves with single stimuli and with interstimulus intervals of 20 and 40 ms ("temporal" stimulation). Finally, both methods were integrated resulting in spatiotemporal stimulation. Statistical testing was performed using linear mixed model analysis of variance. SSEP amplitudes were significantly suppressed after spatial and temporal stimulation. No difference was observed between patients and healthy controls. Spatiotemporal stimulation did not show an additional suppressive effect in any group. Central sensory integration of proprioceptive afferent input is normal in patients with CPRS-related
dystonia
. Other mechanisms may underlie the development of
dystonia
in this disorder.
...
PMID:Spatiotemporal integration of sensory stimuli in complex regional pain syndrome and dystonia. 1937 Mar 88